Literature DB >> 33494798

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference.

Sabine Vogler1, Nina Zimmermann2, Zaheer-Ud-Din Babar3, Reinhard Busse4, Jaime Espin5, Aukje K Mantel-Teeuwisse6, Dimitra Panteli4, Fatima Suleman7, Veronika J Wirtz8.   

Abstract

The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.

Entities:  

Keywords:  Access to medicines; Affordability; Collaboration; Debate; Medicine prices; Policy options; Pricing policies; Reimbursement

Year:  2021        PMID: 33494798      PMCID: PMC7829652          DOI: 10.1186/s40545-021-00300-3

Source DB:  PubMed          Journal:  J Pharm Policy Pract        ISSN: 2052-3211


  1 in total

1.  Reforming pharmaceutical policies in the European Union: a "penguin effect"?

Authors:  Ana M Guillén; Laura Cabiedes
Journal:  Int J Health Serv       Date:  2003       Impact factor: 1.663

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.